Helius Medical Technologies, Inc. Unaudited Condensed Interim Consolidated Balance Sheet The unaudited balance sheet has been filed in order to show compliance with the Nasdaq requirement that the Company maintain a mini
Tuesday, June 17, 2025 1 min read
Key Takeaway: Helius Medical Technologies, Inc. filed an unaudited condensed interim consolidated balance sheet to comply with Nasdaq's requirement for a minimum stockholders' equity of $2.5 million. As of June 17, 2025, the balance sheet demonstrates total assets of $8,246,000 against total liabilities of $1,685,000, indicating a positive current assets to liabilities ratio. However, the report was not audited or reviewed by the independent accounting firm, and there is a notable accumulated deficit.
Market Sentiment Analysis
POSITIVE FACTORS
Company filed unaudited balance sheet to comply with Nasdaq requirements.
Current assets significantly exceed current liabilities.
Cash and cash equivalents are healthy at $6,414,000.
CONCERNS & RISKS
Independent auditor has not reviewed the balance sheet, indicating potential adjustments may be needed.
Company's accumulated deficit stands at $178,043,000, raising concerns about financial stability.
The unaudited balance sheet has been filed in order to show compliance with the Nasdaq requirement that the Company maintain a minimum stockholders' equity of $2.5 million for continued listing. The unaudited balance sheet presents the Company's balance sheet as June 17, 2025 and gives effect to the Company's public offering that closed on June 6, 2025, as adjusted for the cashless exercise of all warrants issued in the offering.
The Company's independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, the balance sheet set forth below. It is possible that the Company or its independent registered public accounting firm may identify items that require the Company to make adjustments to the balance sheet set forth below.
(in thousands, except share data)
June 17, 2025
ASSETS
Current assets
Cash and cash equivalents
$
6,414
Other receivables
84
Inventory, net
1,143
Prepaid expenses and other current assets
512
Total current assets
8,153
Property and equipment, net
93
Total assets
$
8,246
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable
$
858
Accrued and other current liabilities
712
Current portion of deferred revenue
42
Total current liabilities
1,612
Deferred revenue, net of current portion
66
Derivative liability
7
Total liabilities
1,685
Stockholders' equity
Class A common stock, $0.001 par value; 800,000,000 shares authorized; 34,913,081 shares issued and outstanding as of June 17, 2025
35
Additional paid-in capital
184,939
Accumulated deficit
(178,043)
Accumulated other comprehensive loss
(370)
Total stockholders' equity
6,561
Total liabilities and stockholders' equity
$
8,246
Frequently Asked Questions
What is Helius Medical Technologies' stockholders' equity requirement?
The minimum stockholders' equity required is $2.5 million for Nasdaq listing.
When was the unaudited balance sheet for Helius filed?
The unaudited balance sheet was filed as of June 17, 2025.
What was Helius' total assets on June 17, 2025?
Total assets were $8,246,000 on June 17, 2025.
What are Helius' total current liabilities?
Total current liabilities amount to $1,612,000.
What was the accumulated deficit for Helius Medical Technologies?